Cepheid (CPHD) Tops Q1 EPS by 9c; Issues Mixed FY11 Outlook
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Financial Fact:
Research and development: 29.91M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Research and development: 29.91M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Cepheid (NASDAQ: CPHD) reported Q1 EPS of $0.08, $0.09 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $60.22 million versus the consensus estimate of $57.26 million.
Sees FY2011 EPS of $0.31-$0.36, versus the consensus of $0.07. Also sees FY2011 revenue of $245-$255 million, versus the consensus of $253.55 million.
Sees FY2011 EPS of $0.31-$0.36, versus the consensus of $0.07. Also sees FY2011 revenue of $245-$255 million, versus the consensus of $253.55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
- GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
- Veeva Systems (VEEV) Tops Q2 EPS by 13c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
